NHS Midlands and East Branded Medicines - Tranche A
Estimated value
£154.6m
Awarded value
£418.8m
Suppliers
1
Lots
1
Published
13 Feb 2020
Description
NHS Framework for the Midlands and East, Branded Medicines - Tranche A plus Cytokine Modulators and other Monoclonal Antibodies. Offer reference number: CM/PHR/16/5525 CM/PHR/16/5525/01 - NHS Framework for the Midlands and East, Branded Medicines - Tranche A, Period of framework: 1 March 2020 to 28 February 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/16/5525/02 - NHS Framework for the Midlands and East Branded Medicines - Cytokine Modulators and other monoclonal Antibodies, Period of framework: 1 March 2020 to 28 February 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months
Scope
- Reference
- tender_216930/795066
- Total value
- £154,647,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 01 Mar 2020 to 28 Feb 2022
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 02 Oct 2019, 11:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£418.8m
Award date
15 Jan 2020
Contract start
01 Mar 2020
Contract end
28 Feb 2022